Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06736808 · ClinicalTrials.gov registry record · NA

Patient Understanding of Handouts at Different Reading Levels

A NA study, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
156
Enrollment target

NCT06736808: Completed NA study, sponsored by University of North Carolina, Chapel Hill.

NCT06736808 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 156 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06736808, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
156 participants
Enrollment target

Study Summary

The goal of this randomized clinical trial is to learn if participants are better able to understand medical handouts written at below a sixth grade reading level compared to those written at above a sixth grade reading level. The main question it aims to answer is: • Do participants score higher on a knowledge test after reading a handout written at below a sixth grade reading level compared to after reading a handout written at above a sixth grade reading level? Researchers will compare knowledge scores on pelvic organ prolapse after participants read a handout written at an eight grade reading level compared to the same handout re-written to be at a fifth grade reading level. Participants will: * Read a one page handout (written at either above or below a sixth grade reading level) on pelvic organ prolapse * Complete a one page multiple-choice test on pelvic organ prolapse

Primary Outcome

Mean number of correct answers from 0 to 12 on the validated Prolapse Knowledge Questionnaire where 0 indicates 0 correct answers (worst knowledge score) and 12 indicates all correct answers (best knowledge score).

Interventions

  • OTHER Handout Written at Below a Sixth Grade Reading Level
  • OTHER Handout Written at Above a Sixth Grade Reading Level

Trial Details

FieldValue
Enrollment Target 156 participants
Start Date 2024-12-19
Est. Completion 2025-03-21
Phase NA

What the finished NCT06736808 record still lists

NCT06736808 is an interventional study that assigns participants to a tested intervention. The registered 156 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).

The record links to 0 conditions, and to 2 interventions - of which Handout Written at Below a Sixth Grade Reading Level is the first listed.

NCT06736808 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06736808 about?

NCT06736808 is a clinical study titled "Patient Understanding of Handouts at Different Reading Levels". The goal of this randomized clinical trial is to learn if participants are better able to understand medical handouts written at below a sixth grade reading level compared to those written at above a sixth grade reading level. The main question it aims to answer is: • Do participants score higher o...

What is the current status of trial NCT06736808?

This trial is currently completed. It is a NA study. The enrollment target is 156 participants. The study started on 2024-12-19. Estimated completion is 2025-03-21.

What interventions are being tested in trial NCT06736808?

The interventions under investigation include: Handout Written at Below a Sixth Grade Reading Level (OTHER), Handout Written at Above a Sixth Grade Reading Level (OTHER).

Who is sponsoring clinical trial NCT06736808?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06736808's enrollment target sits among peer trials

156 656th of 2000 higher than 1,345 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03082755 · 156 participants · Phase 4

    Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease

  • NCT04047628 · 156 participants · Phase 3

    Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

  • NCT04166877 · 156 participants · Phase 4

    Magnesium Infusion for Pain Management in Critically Ill Trauma Patients

  • NCT04533464 · 156 participants · Phase 2

    MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06736808, the US trial registry maintained by the National Library of Medicine. NCT06736808 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.